Lactobacillus mali strain and uses thereof

The novel Lactobacillus mali CJST01 strain addresses the limitations of current natural sweeteners by producing glucose-transfer steviol glycosides with improved sweetness, solubility, and reduced bitterness, offering a superior alternative to traditional natural sweeteners.

WO2024242287A1PCT designated stage expired Publication Date: 2024-11-28CJ CHEILJEDANG CORP
View PDF 6 Cites 0 Cited by

Patent Information

Application Number
PCT/KR2024/002237
Authority / Receiving Office
WO · WO
Patent Type
Applications
Current Assignee / Owner
Priority Date
2023-05-23
Filing Date
2024-02-21
Publication Date
2024-11-28

AI Technical Summary

Technical Problem

Current natural sweeteners like rebaudioside A, rebaudioside D, and rebaudioside M have limitations due to bitterness, low solubility, and high price, making them less suitable as alternatives to sugar, while synthetic sweeteners raise safety concerns, prompting the need for improved natural alternatives.

Method used

A novel Lactobacillus mali CJST01 strain is developed, which efficiently produces glucose-transfer steviol glycosides, enhancing sweetness preference and solubility, and reducing bitterness, through its glycosyltransferase activity, allowing for the production of glucose-transfer rebaudioside A with improved taste and solubility.

Benefits of technology

The Lactobacillus mali CJST01 strain significantly increases the conversion rate of steviol glycosides to glucose-transfer steviol glycosides, resulting in a sweetener with superior taste quality, reduced off-flavors, and enhanced solubility, addressing the limitations of existing natural sweeteners.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure KR2024002237_28112024_PF_FP_ABST
    Figure KR2024002237_28112024_PF_FP_ABST
Patent Text Reader

Abstract

The present invention relates to a novel Lactobacillus mali CJST01 strain that has excellent steviol glycoside transglycosylation activity, and a method for producing steviol glycoside using same. The novel Lactobacillus mali CJST01 strain has excellent steviol glycoside transglycosylation activity compared to Lactobacillus mali DSM20444 strain which is known to produce steviol glycoside transglycosylation, thereby shortening an enzyme reaction time in a manufacturing process. The steviol glycoside produced by using the strain has an advantage of having better taste quality or flavor than alpha-1,4-linked steviol glycoside and rebaudioside M. In addition, the transglucanized rebaudioside A produced using the Lactobacillus mali CJST01 strain has reduced off-taste and off-flavor and excellent solubility.
Need to check novelty before this filing date? Find Prior Art

Description

Lactobacillus mali strain and its use

[0001] Cross-citation with related application(s)

[0002] This application claims the benefit of priority to Korean Patent Application No. 10-2023-0066300, filed May 23, 2023, the entire contents of which are incorporated herein by reference.

[0003] The present invention relates to a novel Lactobacillus mali strain having excellent glucose-transferred steviol glycoside production ability and a method for producing glucose-transferred steviol glycoside using the same.

[0004]

[0005] Following the World Health Organization (WHO)'s recommendation to reduce daily sugar intake due to concerns about diseases (such as obesity) associated with sugar consumption, governments in developed countries are actively discussing policies to reduce sugar intake. Consequently, the market demand for various alternative sweeteners is increasing, and these are continuously being developed and commercialized. Currently, synthetic high-potency sweeteners (such as saccharin, aspartame, and sucralose) are primarily used as sugar substitutes. However, with ongoing safety concerns regarding synthetic sweeteners, consumer demand for the development of natural alternative sweeteners is growing.

[0006] Stevia, a natural sweetener that has recently been attracting attention, is a sweetener derived from the leaves of a plant called Stevia rebaudiana Bertoni. Steviol glycosides, known as the main sweetener, are approximately 200 to 400 times sweeter than sugar, and rebaudioside A, rebaudioside D, and rebaudioside M are mainly used as food and beverage sweeteners. However, rebaudioside A has a unique bitter taste, and rebaudioside D and rebaudioside M have low solubility and are expensive, which limits their application, limiting their use.

[0007] To solve this problem, a glucose transferase rebaudioside A produced using Lactobacillus mali was studied, which has a structure in which 1 to 4 glucoses are linked in alpha-1,6 to rebaudioside A, and it was confirmed that the sensory characteristics were improved by confirming the improvement in bitterness and superiority in sweetness preference compared to rebaudioside A, a steviol glycoside.

[0008] Lactobacillus mali is a microorganism found in fermented foods such as cider and wine. The present inventors completed this application by confirming that the newly discovered Lactobacillus mali CJST01 strain from various fermented foods is significantly superior to the Lactobacillus mali DSM20444 strain, known to produce glucose-transferred steviol glycosides.

[0009]

[0010] One example of the present invention provides a Lactobacillus mali CJST01 strain.

[0011] Another example of the present invention provides a method for producing a glucose-transferred steviol glycoside using the strain.

[0012] Another example of the present invention provides a glucose-transferred steviol glycoside produced by the above production method.

[0013] Another example of the present invention provides a sweetener comprising the above-mentioned glucose-transferred steviol glycoside.

[0014] Another example of the present invention provides a composition for producing glucose-transferred steviol glycosides, comprising the strain or a culture thereof.

[0015] Another example of the present invention provides a use for the production of a sweetener comprising a glucose-transferred steviol glycoside and / or a glucose-transferred steviol glycoside of the Lactobacillus mali CJST01 strain or a culture thereof.

[0016] Another example of the present invention provides a use of a composition comprising the strain or a culture thereof for the production of a glucose-transferred steviol glycoside and / or a sweetener comprising the glucose-transferred steviol glycoside.

[0017] This is specifically explained as follows. Meanwhile, each description and embodiment disclosed in this application can also be applied to each other description and embodiment. That is, all combinations of the various elements disclosed in this application fall within the scope of this application. Furthermore, the scope of this application is not limited by the specific descriptions described below. Furthermore, those skilled in the art will recognize or be able to identify numerous equivalents to the specific embodiments of this application described in this application using only routine experimentation. Furthermore, such equivalents are intended to be encompassed by this application.

[0018]

[0019] The present application provides a novel Lactobacillus mali strain. The novel Lactobacillus mali strain may be a strain capable of producing glucose-transferred steviol glycosides.

[0020] In this application, as an example, in order to discover a strain with excellent glucose-transferred steviol glycoside production ability, a crude enzyme solution was obtained from a culture solution obtained by homogenizing a fermented food and confirming the stevioside transglycosylation ability, and as a result, a Lactobacillus mali strain with excellent stevioside transglycosylation activity was selected, which was named Lactobacillus mali CJST01 strain, and was deposited with the Korean Collection for Type Cultures (KCTC), a biological resource center of the Korea Research Institute of Bioscience and Biotechnology, an international depository under the Budapest Treaty, on May 8, 2023, and was assigned the accession number KCTC15433BP.

[0021] Therefore, the novel Lactobacillus mali strain may be the Lactobacillus mali CJST01 strain deposited under the deposit number KCTC15433BP.

[0022] The above Lactobacillus mali CJST01 strain has 16S rRNA of sequence number 1.

[0023] The term “steviol glycoside” in this application refers to a natural sweetener, which has a form in which glucose, rhamnose, xylose, etc. are bonded to the 13th and 19th -OH of chemical formula 1 (steviol).

[0024] [Chemical Formula 1]

[0025]

[0026] In general, in chemical formula 1, R1 may have hydrogen (H) bonded to it, or 1 to 3 glucoses may be bonded to it via β bonds, and R2 may have 1 glucose, xylose, or rhamnose bonded to it via β bonds, and 0 to 2 glucoses may be bonded to it via β bonds, but is not limited thereto.

[0027] α- / β-glycosidic bonds are distinguished by the anomeric position and the relative stereochemistry (R or S) of the stereocenter furthest from the position 1 of the monosaccharide. Generally, an α-glycosidic bond forms when the two carbons have the same stereochemistry, whereas a β-glycosidic bond occurs when the two carbons have different stereochemistries.

[0028] The term “glucose-transferred steviol glycoside” in the present application may be a form in which 1 to 9 glucose units are added to the 19-OH position of a steviol glycoside through an α-linkage by a Lactobacillus mali strain using sugar and a steviol glycoside as substrates, and more specifically, may be a form in which 1 to 9 glucose units are added to the glucose bound to the 19-OH position of a steviol glycoside through an α-(1, 6) linkage, but is not limited thereto.

[0029] In the present application, the steviol glycoside may be any one selected from the group consisting of stevioside, rebaudioside A, rebaudioside C, rebaudioside F, dulcoside A, steviolbioside, and rubusoside, but is not limited thereto.

[0030] The above Lactobacillus mali CJST01 strain may have superior glucose-transferred steviol glycoside production ability compared to known Lactobacillus mali strains.

[0031] In the present application, the term “glucose-transferred steviol glycoside production ability” means the ability to produce glucose-transferred steviol glycosides by transferring glucose from a glucose donor to a steviol glycoside, and may be used interchangeably with “glucose-transferred steviol glycoside productivity” or “glucose-transferred steviol glycoside conversion rate”, and the glucose-transferred steviol glycoside production ability, productivity, or conversion rate can be confirmed by reacting a crude enzyme solution obtained after culturing a strain with a steviol glycoside and sugar using a reducing sugar quantification method (DNS method), an HPLC analysis method, or an LC-MS analysis method, but is not limited thereto.

[0032] In one example of the present application, it was confirmed that the Lactobacillus mali CJST01 strain has a higher conversion rate from steviol glycosides to glucose-transferred steviol glycosides under the same conditions than other microorganisms containing known enzymes.

[0033]

[0034] In addition, the present application provides a method for producing a glucose-transferred steviol glycoside using the Lactobacillus mali CJST01 strain.

[0035] The Lactobacillus mali CJST01 strain and the glucose-transferred steviol glycosides are as described above.

[0036] The above method for producing a steviol glycoside by glucose transfer may include a step of reacting sugar and a steviol glycoside in the presence of a Lactobacillus mali strain or a culture thereof.

[0037] In the present application, the culture means a culture solution containing bacterial cells or a crude enzyme solution excluding bacterial cells, and the “culture” includes various substances secreted into the medium by the microorganism during growth together with the medium components prepared for culturing the microorganism, and specifically, includes a glucose transferase having sugar hydrolysis activity. The enzyme having sugar hydrolysis activity may play a role in decomposing sugar into glucose or α-linking 1 to 9 glucose units to the 19-OH position of a steviol glycoside by an α-(1, 6) bond, but is not limited thereto.

[0038] The culture medium used for cultivation must suitably meet the requirements of the specific strain. Culture media for Lactobacillus mali strains are known. For example, the microorganism of the present application can be cultured under aerobic conditions, while controlling temperature, pH, etc., in a conventional medium containing an appropriate carbon source, nitrogen source, amino acid, vitamin, etc. In this case, carbon sources include carbohydrates such as glucose, fructose, and sucrose, and amino acids such as glutamic acid and cysteine. Specifically, natural organic nutrients such as starch hydrolysate and molasses can be used, and carbohydrates such as glucose, fructose, and sterilized pretreated molasses (i.e., molasses converted to reducing sugar) are preferred. Other appropriate carbon sources can be used in various amounts without limitation, but are not limited thereto. Nitrogen sources include inorganic nitrogen sources such as ammonia; amino acids such as glutamic acid and cysteine; and organic nitrogen sources such as peptone, meat extract, and yeast extract. These nitrogen sources can be used alone or in combination, but are not limited thereto. The media may include, but are not limited to, phosphoric acid, potassium dihydrogen phosphate, or dipotassium hydrogen phosphate or their corresponding sodium-containing salts as the personnel. Inorganic compounds may include, but are not limited to, magnesium sulfate, iron sulfate, manganese sulfate, and calcium chloride, and other compounds may include amino acids, vitamins, and appropriate precursors. These media or precursors may be added to the culture in batch or continuous fashion, but are not limited to these.

[0039] During cultivation, compounds such as potassium hydroxide, ammonia, and phosphoric acid can be appropriately added to the culture to adjust the pH of the culture. Furthermore, foaming agents such as fatty acid polyglycol esters can be used to suppress foaming during cultivation. Furthermore, oxygen or an oxygen-containing gas can be injected into the culture to maintain an aerobic state. The culture temperature ranges from 27°C to 37°C, specifically from 30°C to 33°C. The cultivation period can continue until the desired amount of useful substances is obtained, and is typically 20 to 120 hours.

[0040] The method for producing a glucose-transferred steviol glycoside of the present application may include the steps of preparing a composition comprising the Lactobacillus mali strain or a culture thereof, sugar, and steviol glycoside; and the step of mixing the compositions.

[0041] As a specific example, the manufacturing method may include a step of administering an additive to a composition comprising the Lactobacillus mali strain or a culture thereof.

[0042] In another specific example, the additive is a cryoprotectant or excipient, and a drying step may be additionally included after the step of administering the additive. The cryoprotectant and excipient are as described below.

[0043] The above steviol glycoside may be any one selected from the group consisting of stevioside, rebaudioside A, rebaudioside C, rebaudioside F, dulcoside A, steviolbioside, and rubusoside, but is not limited thereto.

[0044]

[0045] In addition, the present application provides a glucose-transferred steviol glycoside produced by a method for producing the glucose-transferred steviol glycoside, and a sweetener comprising the glucose-transferred steviol glycoside.

[0046] The above-mentioned manufactured glucose-transferred steviol glycoside and the sweetener containing the same may have reduced off-flavor and off-flavor and improved sweetness.

[0047]

[0048] In addition, the present application provides a composition for producing glucose-transferred steviol glycosides comprising the Lactobacillus mali CJST01 strain or a culture thereof.

[0049] The Lactobacillus mali CJST01 strain and the glucose-transferred steviol glycosides are as described above.

[0050] The composition may further comprise a cryoprotectant or excipient. The cryoprotectant or excipient may be, but is not limited to, a non-naturally occurring substance or a naturally occurring substance. In another specific example, the cryoprotectant or excipient may be, but is not limited to, a substance with which the Lactobacillus mali CJST01 strain does not naturally come into contact, or a substance that is not naturally contained together with the strain. In another specific example, the composition may further comprise at least one cryoprotectant selected from the group consisting of glycerol, trehalose, maltodextrin, skimmed milk powder, and starch, and / or at least one excipient selected from the group consisting of glucose, dextrin, and skimmed milk. The cryoprotectant of the present application may be included in an amount of 0.01 wt% to 20 wt%, or 0.01 wt% to 10 wt%, based on the total weight of the composition. Specifically, the glycerol may be included in an amount of 5 wt% to 20 wt%, the trehalose may be included in an amount of 2 wt% to 10 wt%, the maltodextrin may be included in an amount of 2 wt% to 10 wt%, the skimmed milk powder may be included in an amount of 0.5 wt% to 2 wt%, and the starch may be included in an amount of 0.1 wt% to 1 wt%. In addition, the excipient may be included in an amount of 75 wt% to 95 wt%, or 85 wt% to 95 wt%, based on the total weight of the composition.

[0051] The above composition may be used in, but is not limited to, liquid, granular, or powder form.

[0052]

[0053] Additionally, the present application provides a use for producing a sweetener comprising a glucose-transferred steviol glycoside and / or a glucose-transferred steviol glycoside of the Lactobacillus mali CJST01 strain or a culture thereof.

[0054] In addition, the present application provides a use for producing a sweetener comprising a glucose-transferred steviol glycoside and / or a glucose-transferred steviol glycoside of a composition comprising the Lactobacillus mali CJST01 strain or a culture thereof.

[0055] The Lactobacillus mali CJST01 strain and the glucose-transferred steviol glycosides are as described above.

[0056]

[0057] The present invention relates to a novel Lactobacillus mali strain and a method for producing a glucose-transferred steviol glycoside using the same. The novel Lactobacillus mali CJST01 strain has superior steviol glycoside transglycosylation activity and higher productivity than the Lactobacillus mali DSM20444 strain known to produce a glucose-transferred steviol glycoside, thereby shortening the enzymatic reaction time in the manufacturing process. In addition, the steviol glycoside produced using the strain has an advantage of superior taste quality or flavor compared to alpha-1,4-linked steviol glycosides and rebaudioside M. In addition, the glucose-transferred steviol glycoside A produced using the Lactobacillus mali CJST01 strain has reduced off-flavor and off-odor, and excellent solubility.

[0058]

[0059] Figure 1 is a diagram showing the results of measuring the sugar hydrolysis activity of the Lactobacillus mali CJST01 strain using the DNS method, comparing it with the control strain, Lactobacillus mali DSM20444.

[0060] Figure 2 is a diagram showing the results of comparing the conversion rate of glucose transfer rebaudioside A from rebaudioside A according to the amount of crude enzyme solution added to the Lactobacillus mali CJST01 strain and the control strain Lactobacillus mali DSM20444 strain.

[0061] Figure 3 is a diagram showing a chromatogram of a reaction solution analyzed by HPLC after adding 15% of the crude enzyme solution of the Lactobacillus mali CJST01 strain and the control strain Lactobacillus mali DSM20444 strain.

[0062] Figure 4 is a diagram showing the results of HPLC analysis of the reaction solution components after adding 5-fold concentrated Lactobacillus mali CJST01 crude enzyme solution to 10% rebaudioside A and 10% sugar to a concentration of 10%.

[0063] Figure 5 is a diagram showing the results of analyzing the reaction solution components by LC-MS after adding 5-fold concentrated Lactobacillus mali CJST01 crude enzyme solution to 10% rebaudioside A and 10% sugar to a concentration of 10%.

[0064] Figure 6 is a diagram showing the results of analyzing the reaction solution components by LC-MS after adding 5-fold concentrated Lactobacillus mali CJST01 crude enzyme solution to 10% rebaudioside A and 10% sugar to a concentration of 10%.

[0065] Figure 7 is a chromatogram comparing the steviol glycoside reaction before and after the Lactobacillus mali CJST01 crude enzyme solution.

[0066] Figure 8 shows the results of intensity analysis of detailed flavor properties of glucose transferase rebaudioside A prepared with Lactobacillus mali CJST01 crude enzyme solution.

[0067]

[0068] Hereinafter, the present invention will be described in more detail with reference to the following examples. However, these examples are only intended to illustrate the present invention, and the scope of the present invention is not limited by these examples.

[0069]

[0070] Example 1. Screening of a novel strain having glucose transfer activity to stevioside.

[0071] The microbial library stocks in our company were isolated from samples collected from traditional fermented foods such as kimchi, soy sauce, vinegar, and fermented liquor and their manufacturing processes, and spread on MRS agar medium and cultured at 30°C for 24 hours. Among them, strains with fast growth rates were visually selected, and the colonies were inoculated into 3 mL of MRS broth and cultured at 30°C for 24 hours. Each culture solution was centrifuged at 8,000 rpm for 10 minutes to separate the cell bodies and supernatant, and the supernatant (crude enzyme solution) was recovered. The sugar hydrolysis ability of each crude enzyme solution was confirmed using the DNS method, and the stevioside glycosyltransferase ability was confirmed by reacting with 5% each of sugar and stevioside, which are shown in Table 1.

[0072] Strain name Sucrose hydrolysis ability Stevioside sugar transfer ability Bifidobacterium bifidum × × Lactobacillus reuteri O × Lactobacillus casei O × Lactobacillus plantarum O × Lactobacillus salivarius O × Lactobacillus mali O ×

[0073] As shown in Table 1, a total of six strains were selected, including Bifidobacterium bifidum, Lactobacillus reuteri, Lactobacillus casei, Lactobacillus plantarum, Lactobacillus salivarius, and Lactobacillus mali. As a result of confirming sugar hydrolysis activity and stevioside transglycosylation activity, five of the six strains were found to have sugar hydrolysis activity, but only the Lactobacillus mali strain was confirmed to have stevioside transglycosylation activity.

[0074]

[0075] Example 2. Identification of 16S rRNA sequences of selected Lactobacillus mali strains.

[0076] As a result of confirming the 16S rRNA sequence of the Lactobacillus mali strain selected in Example 1, it was confirmed that there was no strain with the same sequence and that it was different from the base sequences of known Lactobacillus mali strains. Therefore, it was confirmed that the Lactobacillus mali strain selected in Example 1 was a novel Lactobacillus mali strain, and the strain name was named Lactobacillus mali CJST01, and the 16S rRNA sequence was registered in NCBI GenBank.

[0077] In addition, the Lactobacillus mali CJST01 strain was deposited with the Korean Collection for Type Cultures (KCTC), an international depository under the Budapest Treaty, on May 8, 2023, and was assigned the accession number KCTC15433BP.

[0078]

[0079] Example 3. Confirmation of sugar hydrolysis activity of Lactobacillus mali CJST01 strain.

[0080] To confirm that the novel Lactobacillus mali CJST01 strain has excellent sugar hydrolysis activity, it was compared with the sugar hydrolysis activity of the Lactobacillus mali DSM20444 strain, which is known to have sugar hydrolysis activity.

[0081] Specifically, two strains, Lactobacillus mali CJST01 and Lactobacillus mali DSM20444, were cultured in MRS broth supplemented with sugar, and then the culture solution was centrifuged at 8000 rpm for 10 minutes to separate the cells and the supernatant, and only the supernatant (crude enzyme solution) was collected. The obtained crude enzyme solution was reacted with sugar, and the sugar hydrolysis activity was measured using the reducing sugar quantitation method (DNS method), which is shown in Fig. 1. After mixing each fraction with a 200 mM sugar solution in 50 mM sodium acetate buffer at a ratio of 1:1, the mixture was reacted in a 40°C water bath for 10 minutes, and then deactivated at 100°C. The DNS reagent was added at a ratio of 1:3, mixed, and reacted at 100°C for 5 minutes, and then the DNS reaction was immediately stopped on ice. Then, the absorbance (OD) of the DNS reagent was measured at 575 nm and then input into the prepared fructose standard curve to confirm activity. Here, 1 Unit is defined as the amount (mL) of enzyme that increases 1 μmole of reducing sugar per minute.

[0082] As a result, as shown in Fig. 1, it was confirmed that the novel Lactobacillus mali CJST01 strain exhibited sugar hydrolysis activity that was approximately 1.7 times higher than that of the Lactobacillus mali DSM20444 strain.

[0083]

[0084] Example 4. Evaluation of conversion of glucose from rebaudioside A to rebaudioside A

[0085] The conversion rate of rebaudioside A to glucose transfer rebaudioside A in the crude enzyme solutions of Lactobacillus mali CJST01 strain and Lactobacillus mali DSM20444 strain prepared in Example 3 was compared as follows.

[0086] Specifically, 10% each of rebaudioside A (Daepyung) and sugar (CJ CheilJedang) were added to 50 μM sodium acetate buffer (pH 5.0), and 5%, 15%, or 25% each of the crude enzyme solutions of the two strains of Lactobacillus mali prepared in Example 3 were added and reacted at 40°C for 24 hours. After the reaction, the mixture was inactivated at 100°C, and the conversion rate of glucose transfer to rebaudioside A was confirmed by HPLC. The results are shown in Fig. 2. In addition, the chromatograms of each reaction solution after the addition of 15% of the crude enzyme solution were compared and shown in Fig. 3. The HPLC analysis conditions are shown in Table 2 below.

[0087] DetectorUV 210 nmColumnCapcell pak C18 MG II (4.6 x 250, 5 um)Column temp.40℃Mobile phase30% acetonitrileisocraticFlow rate1.0 mL / min

[0088] As a result of comparing the conversion rate into rebaudioside A according to the amount of crude enzyme solution added from two strains of Lactobacillus mali, as shown in Fig. 2, when the crude enzyme solution was added at 5%, 15%, and 25%, respectively, the conversion rate of the crude enzyme solution of the Lactobacillus mali CJST01 strain was approximately 1.3 to 1.5 times higher than that of the crude enzyme solution of the Lactobacillus mali DSM20444 strain. This shows that when the Lactobacillus mali CJST01 strain is used compared to the Lactobacillus mali DSM20444 strain, less Lactobacillus crude enzyme solution is required for the production of glucose transaminase rebaudioside A at the same conversion rate, which is advantageous in the glucose transaminase rebaudioside A production process.

[0089] In addition, as a result of comparing the chromatograms analyzed by HPLC of the reaction solution after the addition of 15% of the crude enzyme solution of two strains of Lactobacillus mali, it was confirmed that when the crude enzyme solution of two strains was added, the peak of the raw material, Rebaudioside A, decreased and the peak of the glucose-transferred Rebaudioside A increased after the reaction. Furthermore, it was confirmed that the Rebaudioside A peak of the reaction solution to which the crude enzyme solution of the Lactobacillus mali CJST01 strain was added decreased more than that of the reaction solution to which the crude enzyme solution of the Lactobacillus mali DSM20444 strain was added.

[0090]

[0091] Example 5. Evaluation of the conversion rate of glucose transfer rebaudioside A according to reaction conditions.

[0092] The conversion rate of rebaudioside A to glucose transfer rebaudioside A in crude enzyme solutions of Lactobacillus mali CJST01 strain and Lactobacillus mali DSM20444 strain according to reaction conditions was evaluated.

[0093] Specifically, the conversion rate of rebaudioside A was analyzed by HPLC in the same manner as in Example 4 under the conditions of adding 5%, 10%, 15%, or 25% of the crude enzyme solution of the Lactobacillus mali CJST01 strain and the Lactobacillus mali DSM20444 strain prepared in Example 3, a substrate (rebaudioside A) concentration of 5%, 7%, or 10%, and a reaction time of 6 hours, 24 hours, or 48 hours, and the results are shown in Tables 3 and 4 below.

[0094] Lactobacillus mali DSM20444 strain crude enzyme solution Rebaudioside A conversion rate by reaction conditions Substrate concentration (Reb A) Added crude enzyme solution Reaction time (h) 62 44 85% 5% 15.5 47.9 69.2 10% 27.6 70.8 8.0 15% 39.3 84.1 93.2 25% 54.2 90.8 92.37% 5% 11.7 38.8 57.8 10% 21.6 59.5 80.2 15% 30.9 75.2 90.1 25% 44.6 87.7 93.4 10% 5% 8.3 29.0 42.4 10% 15.5 47.0 67.4 15% 21.7 59.5 79.5 25% 32.4 75.7 89.0

[0095] Lactobacillus mali CJST01 strain crude enzyme solution Rebaudioside A conversion rate by reaction conditions Substrate concentration (Reb A) Added crude enzyme solution Reaction time (h) 624485% 5% 23.96 5.08 4.710% 40.18 4.59 3.315% 55.99 2.89 4.325% 72.09 3.09 1.27% 5% 17.75 2.07 3.310% 34.27 9.29 2.215% 44.88 7.59 3.425% 61.49 3.19 2.610% 5% 12.94 1.16 0.710% 23.06 2.18 1.615% 33.07 6.89 0.025% 49.28 9.19 1.5

[0096] As a result of confirming the rebaudioside A conversion rate of crude enzyme solutions of two strains of Lactobacillus mali according to the reaction conditions, as shown in Tables 3 and 4, when the substrate concentration was 10%, the crude enzyme solution addition amount was 5%, 10%, or 15%, and the reaction time was 6 to 48 hours, the crude enzyme solution of the Lactobacillus mali DSM20444 strain showed a glucose transaminase rebaudioside A conversion rate of 8 to 80%, and the crude enzyme solution of the Lactobacillus mali CJST01 strain showed a glucose transaminase rebaudioside A conversion rate of 13 to 90%. From these results, it can be confirmed that when the Lactobacillus mali CJST01 strain is used, a higher conversion rate is shown at the same substrate concentration or crude enzyme solution addition amount.

[0097] In addition, the reaction solution containing the crude enzyme solution of the Lactobacillus mali DSM20444 strain showed a rebaudioside A conversion rate of 90% under the conditions of 7% substrate concentration, 15% crude enzyme solution addition amount, and 48 hours of reaction time, and the reaction solution containing the crude enzyme solution of the Lactobacillus mali CJST01 strain showed a rebaudioside A conversion rate of 90% under the conditions of 10% substrate concentration, 15% crude enzyme solution addition amount, and 48 hours of reaction time. Through this, it can be seen that when the crude enzyme solution of the Lactobacillus mali CJST01 strain is used, a reaction solution with the same conversion rate can be obtained at a high substrate concentration.

[0098]

[0099] Example 6. Analysis of glucose transferase rebaudioside A

[0100] To determine how many glucose units are bound to the converted glucose transaminase Rebaudioside A by adding the crude enzyme solution of Lactobacillus mali strain, the following analysis was performed.

[0101] Specifically, 10% each of rebaudioside A (Daepyung) and sugar (CJ CheilJedang) were added to 50 μM sodium acetate buffer (pH 5.0), and the crude enzyme solution of the Lactobacillus mali CJST01 strain prepared in Example 3 was concentrated 5-fold and added to a 10% concentration, followed by reaction at 40°C for 24 hours. After the reaction, it was inactivated at 100°C, and the results of HPLC analysis and LC-MS analysis under the conditions of Table 5 below are shown in Figures 4 to 6.

[0102] DetectorUV at 210 nm (4nm bw)Ref: 360 nm (100nm bw)ColumnNH2(4.6 * 250mm, 5um)ex. Agilent Zorbax NH2Column temp.40℃GradientTime(min)A (%)B (%)08020280209050509180201008020Injection vol.12 uLFlow rate1 mL / min

[0103] As a result, as shown in FIGS. 4 to 6, it was confirmed that rebaudioside A of the reaction solution prepared using the crude enzyme solution of Lactobacillus mali CJST01 strain had 1 to 9 glucose units transferred to rebaudioside A.

[0104]

[0105] Example 7. Evaluation of glucose transfer activity by crude enzyme solution of Lactobacillus mali strain containing different steviol glycosides.

[0106] To evaluate the glucose transfer activity of the crude enzyme solution of Lactobacillus mali strain by steviol glycosides, the following experiments were performed.

[0107] Specifically, 10% each of 12 types of steviol glycosides (stevioside, rebaudioside A, B, C, D, E, F, M, N, dulcoside A, steviol bioside, rubusoside) and sugar (CJ CheilJedang) were added as substrates to 50 μM sodium acetate buffer (pH 5.0), and the crude enzyme solution of the two strains of Lactobacillus mali prepared in Example 3 was added and reacted at 40°C for 24 hours. After the reaction, it was inactivated at 100°C, and the production of glucose-transferred steviol glycosides was confirmed by HPLC, and the results are shown in Table 6 and Figure 7 below.

[0108] Steviol GlycosideDSM20444CJST01Rebaudioside AΟΟRebaudioside B--Rebaudioside CΟΟRebaudioside D--Rebaudioside EΟ-Rebaudioside FΟΟRebaudioside M--Rebaudioside N--SteviosideΟΟDulcoside AΟΟSteviolbioside-ΟRubusosideΟΟ

[0109] As a result, as shown in Table 6 and Fig. 7, the crude enzyme solution of Lactobacillus mali CJST01 strain was found to have glucose transfer activity for stevioside, rebaudioside A, C, and F, dulcoside A, steviolbioside, and ruboside among 12 steviol glycosides. It was confirmed that rebaudioside E was active only in the crude enzyme solution of Lactobacillus mali DSM20444, whereas steviolbioside was active only in the crude enzyme solution of Lactobacillus mali CJST01.

[0110]

[0111] Example 8. Sensory descriptive analysis of a glucose-transferase rebaudioside A aqueous solution.

[0112] The sensory differences between CJST01 glucose transaminase rebaudioside A (CJ), manufactured by the method for manufacturing the above glucose transaminase steviol glycoside, and comparative samples rebaudioside M (RM) and alpha-1,4 glucose transaminase rebaudioside A (A14) were analyzed.

[0113] Specifically, this evaluation was conducted by recruiting a professional sensory panel and using descriptive analysis. In advance, 100 female consumers sensitive to sweetness between the ages of 19 and 40 were targeted to calculate the concentration corresponding to the same sweetness. The sensory evaluation method used was the Paired Comparison Test, and the final calculated concentration is shown in Table 7 below. At this time, the concentrations of the CJ and A14 samples were divided into quintiles based on the RM concentration, and the consumers were asked to select the closest concentration. The manufacturing method was to dissolve the substance in drinking purified water at a specified concentration (w / w) to prepare a taste-ready state, and the samples were provided to the consumer panel in 10 mL portions in transparent plastic cups. Two samples were randomly assigned, and the sample that was perceived as sweeter was selected. Based on this, the sample in which statistical equivalence occurred among the overall differences between the samples was calculated as the final sample concentration for descriptive analysis.

[0114] List of samples for evaluation to verify the sensory superiority of glucose-transferred steviol glycosides. Classification, Output concentration, Remarks. CJ 0.1 197%, Alpha-1,6 glucose-transferred rebaudioside ARM 0.06 96%, Steviol glycoside A 14 0.2 351%, Alpha-1,4 glucose-transferred rebaudioside A

[0115] Sensory evaluations using descriptive analysis were conducted using the sample concentrations derived above, as described below. The purpose of the sensory evaluation was to determine the overall sensory profile of each sweetener solution when the sweetness level was the same. The sensory evaluations were conducted twice with six trained expert panelists.

[0116] Specifically, samples were provided at room temperature in 10 mL portions in transparent plastic cups, and the panelists were provided with three glasses of each sample and described the sensory form. The evaluation was conducted on randomly provided samples, and a rest period of 2 to 3 minutes was placed between samples to eliminate the sensory influence between samples while investigating detailed flavor attributes. The evaluation items that the panelists could feel were derived through a preliminary sample evaluation, and the following standard samples were provided for detailed flavor / mouthfeel characteristics. The overall contents of this are shown in Table 8 below.

[0117] AttributeDefinitionReferenceFlavorFlowerThe unique fragrant floral scent of freesia flowersSugar 8% aqueous solution + freesia flavor (Seoul flavor) 0.00035%The unique flavor of honeyMiscellaneous flowersHoney flavor (Seoul flavor) 0.02% aqueous solutionCloveThe unique flavor of clovesClove flavor (Seoul flavor) 0.005% aqueous solutionWaterFishy flavor felt in fish tanks or old water -MetalThe cool flavor felt in metallic substances such as ironLiquid iron preparation, stainless steel spoonMouthfeelCoolingThe feeling of cooling in the mouth after swallowing the sampleMint flavor (Firmenich flavor) 0.002% aqueous solutionAstringent sensationThe feeling of shrinking or drying the tissues in the mouth when holding the sample in the mouth or swallowing itTannic Acid (Namyoungsa) 0.021% aqueous solution

[0118] As shown in Table 8, sensory evaluation using descriptive analysis resulted in the sensory characteristics of five sweeteners: sweetness, bitterness, five flavor characteristics, and two mouthfeel characteristics. For bitterness, standard substances were provided according to intensity (2 points: anhydrous caffeine 0.055%, 4 points: anhydrous caffeine 0.067%).

[0119] The results of the intensity analysis for detailed flavor attributes, etc. are shown in Table 9 below, and the results visualized using Spider Map are shown in Figure 8.

[0120]

[0121] Strength for detailed properties 1) Analysis Results Detailed Items CJRMA 14 Bitterness 2.5 1.3 4.8 Floral Flavor 1.5 1.1 3 Honey Flavor 1.1 1.1 1.8 Watery Flavor 1.4 1 Metallic 1.3 2.8 1.5 Cooling 1.5 1.3 1.3 Astringent Sensation 21.5 3.5

[0122] 1)Means of two replicates. Data were scored on a 15 point category scale, where 1 - week intensity of the attribute and 15 = strong intensity of the attribute. Values ​​within a row not sharing a superscript letter are significantly different (p<0.05 Duncan's multiple range test).

[0123] As shown in Table 8 and Fig. 8, RM showed a strong 'watery flavor' and a strong metallic characteristic, and 'bitter taste and astringent sensation' were expressed weakly compared to the A14 sample. In the case of the A14 sample, it showed a relatively strong 'bitter taste / clove flavor / astringent sensation' characteristic. In the case of the CJ sample, the metallic intensity was weaker than the RM sample, and the bitter taste / astringent sensation was evaluated to be at an equivalent level. Compared to the A14 sample, the bitter taste / astringent sensation attribute was expressed weakly, and the intensities of the remaining attributes were investigated to be equivalent.

[0124] In other words, the above results confirmed that the CJ sample had superior sensory performance as a sweetener compared to the comparative samples (fewer off-notes). Since sweeteners are intended to replace sugar, no other characteristics other than "sweetness" are required. Considering their application to a variety of foods, these characteristics are crucial for universal use. Therefore, when synthesizing the results of this descriptive analysis, it can be concluded that the glucose transferase rebaudioside A of the present invention has proven its superiority as a food sweetener.

[0125]

[0126] Example 9. Solubility evaluation of glucose transferase rebaudioside A

[0127] To evaluate the solubility of steviol glycosides and glucose transferase rebaudioside A, 2 g of each rebaudioside A (RebA), rebaudioside D (RebD), rebaudioside M (RebM), and stevioside (STV) were mixed with 10 ml of distilled water in an aqueous solution, and 8 g of glucose transferase rebaudioside A (RebA-Glu) was mixed with 10 ml of distilled water in an aqueous solution, and dissolved using a sonicator at 50°C for 60 minutes. This was incubated in an incubator at 10, 25, 40, and 55°C for 4 days. Each aqueous solution was centrifuged at 12,000 rpm for 10 minutes, and 1 ml of the supernatant was dried in a dry oven at 105°C to measure the solubility, which is shown in Table 10. At this time, the glucose transfer rebaudioside A was obtained by manufacturing it in the same manner as the glucose transfer rebaudioside A used in Example 7 above.

[0128] Temperature (℃)Solubility (mg / ml)RebARebDRebMSTVRebA-Glu1054412400↑2551421400↑4061637400↑551229160↑400↑

[0129] As a result, as shown in Table 10, the solubility of the glucose transferase rebaudioside A was significantly increased compared to the reaction substrate rebaudioside A, and it was confirmed that the solubility was significantly improved compared to other steviol glycosides rebaudioside D, rebaudioside M, and stevioside.

[0130]

[0131] From the above description, those skilled in the art will understand that the present application can be implemented in other specific forms without altering the technical concept or essential features thereof. In this regard, it should be understood that the embodiments described above are illustrative in all respects and not restrictive. The scope of this application should be interpreted to include all changes or modifications derived from the meaning and scope of the following claims and their equivalent concepts, rather than the detailed description above.

[0132]

[0133] [Accession number]

[0134] Name of depositor: Korea Research Institute of Bioscience and Biotechnology, Biological Resource Center (KCTC)

[0135] Accession number: KCTC15433BP

[0136] Date of acceptance: 20230508

[0137]

[0138]

Claims

1. Lactobacillus mali CJST01 strain deposited under the deposit number KCTC15433BP.

2. A strain according to claim 1, wherein the strain has a 16S rRNA sequence of sequence number 1.

3. A strain according to claim 1, wherein the steviol glycoside is any one selected from the group consisting of stevioside, rebaudioside A, rebaudioside C, rebaudioside F, dulcoside A, steviolbioside, and rubusoside.

4. A method for producing a glucose-transferred steviol glycoside using the strain of paragraph 1.

5. In paragraph 4, The method comprises a step of reacting sugar and steviol glycoside in the presence of the Lactobacillus mali strain or a culture thereof, wherein the method comprises a method for producing a glucose-transferred steviol glycoside.

6. A method for producing a glucose-transferred steviol glycoside, wherein the steviol glycoside in paragraph 4 is any one selected from the group consisting of stevioside, rebaudioside A, rebaudioside C, rebaudioside F, dulcoside A, steviolbioside, and rubusoside.

7. A method for producing a glucose-transferred steviol glycoside in claim 6, wherein the steviol glycoside is a steviol glycoside in which glucose is added by linking it to the 19-OH position of the steviol glycoside through an α-(1, 6) bond.

8. A method for producing a glucose-transferred steviol glycoside in claim 7, wherein the steviol glycoside contains 1 to 9 glucose units.

9. A glucose-transferred steviol glycoside produced by the method of any one of claims 4 to 8.

10. In the 9th paragraph, the steviol glycoside is any one selected from the group consisting of stevioside, rebaudioside A, rebaudioside C, rebaudioside F, dulcoside A, steviolbioside, and rubusoside.

11. A sweetener containing the glucose-transferred steviol glycoside of Article 9.

12. A composition for producing glucose-transferred steviol glycosides, comprising the strain of paragraph 1 or a culture thereof.

Citation Information

Patent Citations

  • Lactobacillus mali strain and uses thereof

    KR1020240169174A

  • Method of preparing Milk confectionery containing Probiotics

    KR1020170036324A

  • Microorganism having Anti-Obesity Ability and Pharmaceutical Composition Containing the same

    KR1020180088353A

  • Electric vehicle charging device with improved ease of use

    KR1020230172128A

  • Encapsulation system for protection of probiotics during processing

    WO2012142153A1